Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease

被引：14

作者：

Gupta, S ^{[1
]}

机构：

[1] St George Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England

来源：

AMERICAN HEART JOURNAL | 1999年 / 138卷 / 05期

关键词：

D O I：

10.1016/S0002-8703(99)70296-6

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：S539 / S541

页数：3

共 13 条

[1]

ANDERSON JL, 1998, 47 SCI SESS AM COLL

[2]

Bengtson A, 1996, EUR HEART J, V17, P1846

[3]

Anti-inflammatory effects of macrolide antibiotics [J].

Black, PN .

EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (05) :971-972

[4]

Chronic infections and coronary heart disease: is there a link? [J].

Danesh, J ;

Collins, R ;

Peto, R .

LANCET, 1997, 350 (9075) :430-436

[5]

THE PHARMACOKINETICS OF AZITHROMYCIN IN HUMAN SERUM AND TISSUES [J].

FOULDS, G ;

SHEPARD, RM ;

JOHNSON, RB .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :73-82

[6]

Chlamydia pneumoniae and coronary heart disease [J].

Gupta, S ;

Camm, AJ .

BRITISH MEDICAL JOURNAL, 1997, 314 (7097) :1778-1779

[7]

Is there an infective aetiology to atherosclerosis? [J].

Gupta, S ;

Camm, AJ .

DRUGS & AGING, 1998, 13 (01) :1-7

[8]

Gupta S, 1997, CIRCULATION, V96, P404

[9]

GUPTA S, 1998, BR J CARDIOL, V5, P65

[10]

GUPTA S, 1997, J AM COLL CARDIOL, V755, P209

← 1 2 →